000 01329 a2200397 4500
005 20250514191608.0
264 0 _c20040618
008 200406s 0 0 eng d
022 _a1533-001X
040 _aNLM
_beng
_cNLM
100 1 _aBaker, Danial E
245 0 0 _aThe short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
_h[electronic resource]
260 _bReviews in gastroenterological disorders
_c2004
300 _a86-91 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAminosalicylic Acids
_xadverse effects
650 0 4 _aChild
650 0 4 _aClinical Trials as Topic
650 0 4 _aColitis, Ulcerative
_xdiagnosis
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Labeling
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMesalamine
_xpharmacology
650 0 4 _aMiddle Aged
650 0 4 _aPhenylhydrazines
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aSensitivity and Specificity
650 0 4 _aSulfasalazine
_xpharmacology
700 1 _aKane, Sunanda
773 0 _tReviews in gastroenterological disorders
_gvol. 4
_gno. 2
_gp. 86-91
999 _c14892869
_d14892869